Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
Medly ECG Session 6 RBBB And LBBB JBN coverClinical notesMedly ECG Session 6 RBBB And LBBB JBNCardiology· 25 pages
Medly ECG Session 4 P Waves And PR SMK 02.07.26 coverClinical notesMedly ECG Session 4 P Waves And PR SMK 02.07.26Cardiology· 34 pages
Medly ECG Session 8 Revision I IM 30.07.26 coverClinical notesMedly ECG Session 8 Revision I IM 30.07.26Cardiology· 20 pages
Medly ECG Session 7 T Wave Abnormalities DI 23.0926 coverClinical notesMedly ECG Session 7 T Wave Abnormalities DI 23.0926Cardiology· 42 pages
THE ENDURING WISDOM OF BOOKS IN THE DIGITAL AGE OF MEDICINE coverClinical notesTHE ENDURING WISDOM OF BOOKS IN THE DIGITAL AGE OF MEDICINEDepartment of Cardiovascular Medicine, Ospedale di Circolo, Busto Anizio (VA), Italy·Cardiology· 2 pagesThis document reflects on the enduring value of printed medical books in an era dominated by digital information and artificial intelligence, emphasizing the depth and humanity they provide in medical education.
DYS LIPIDEMIA EVALUATION AND MANAGEMENT coverGuidelines & protocolsDYS LIPIDEMIA EVALUATION AND MANAGEMENTAmerican College of Cardiology (ACC)/American Heart Association (AHA)·Cardiology· 2026· 2 pagesThis document provides clinical guidelines for the evaluation and management of dyslipidemia, focusing on risk assessment and lipid-lowering therapy recommendations.
What's new in cardiovascular medicine - UpToDate coverClinical reviewsWhat's new in cardiovascular medicine - UpToDateUpToDate, Inc.·Cardiology· 2026· 12 pagesThis document provides updates on recent findings and recommendations in cardiovascular medicine, highlighting significant changes in management strategies and treatment outcomes.
LITTLE BLACK BOOK OF ECG SECRETS coverClinical notesLITTLE BLACK BOOK OF ECG SECRETSFranz Wiesbauer & the Medmastery team·Cardiology· 2024· 13 pagesThis book provides several electrocardiogram (ECG) cases designed to enhance the reader's diagnostic skills through a case-based learning approach.
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health coverGuidelines & protocols2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular HealthAmerican College of Cardiology·Cardiology· 2025· 20 pagesThis document provides expert consensus recommendations on medical weight management aimed at optimizing cardiovascular health, developed by the American College of Cardiology.
DYSLIPIDAEMIA AND HEPATIC STEATOSIS: MECHANISMS AND IMPLICATIONS FOR LIPID-LOWERING THERAPY coverClinical reviewsDYSLIPIDAEMIA AND HEPATIC STEATOSIS: MECHANISMS AND IMPLICATIONS FOR LIPID-LOWERING THERAPYMaurizio Averna, M. Mahmood Hussain, Giuseppe Danilo Norata·Cardiology· 2026· 16 pagesThis review article discusses the interconnectedness of dyslipidaemia and hepatic steatosis, particularly in the context of obesity and diabetes mellitus, and their implications for cardiovascular disease.
BEYOND THE HEART coverClinical reviewsBEYOND THE HEARTKayanne BA, Dalia BS, Issam MD, Mariam MD·Cardiology· 11 pagesThis narrative review provides a comprehensive overview of Marfan syndrome from a cardiologist's perspective, focusing on its pathophysiology, cardiac involvement, and management strategies.
Desimone Et Al 2026 Infective Endocarditis Diagnosis Antibiotic coverClinical reviewsDesimone Et Al 2026 Infective Endocarditis Diagnosis AntibioticAmerican Heart Association·Cardiology· 27 pagesThis scientific statement from the American Heart Association provides an updated overview of infective endocarditis, covering recent changes in incidence, epidemiology, diagnostic methods, and treatment options. It emphasizes the evolving landscape of diagnosis and management, including novel techniques and the importance of multidisciplinary teams.
LDL CHOLESTEROL LOWERING WITH EVOLOCUMAB BEFORE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION coverClinical reviewsLDL CHOLESTEROL LOWERING WITH EVOLOCUMAB BEFORE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTIONAMUNDSEN Investigators of the ACTION Study Group·Cardiology· 2026· 9 pagesThis study investigates the effects of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibition using evolocumab on LDL cholesterol levels in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
INTEGRATED MANAGEMENT STRATEGIES FOR HYPERTENSION AND DIABETES IN CARDIOVASCULAR coverClinical reviewsINTEGRATED MANAGEMENT STRATEGIES FOR HYPERTENSION AND DIABETES IN CARDIOVASCULARDepartment of Cardiology, Rama Medical College and Hospital; Santosh Cardiac Care Centre; PCET’s Pimpri Chinchwad University; Dr. N. D. Desai Faculty of Medical Science and Research; Smt. B. K. Shah Medical Institute and Research Centre; National Medical·Cardiology· 2026· 12 pagesThis open access review article discusses the interconnectedness of type 2 diabetes and hypertension, emphasizing the need for integrated management strategies to mitigate cardiovascular risks.
TRANSCATHETER AORTIC VALVE REPLACEMENT OR MEDICAL TREATMENT FOR PARADOXICAL LOW-FLOW, LOW-GRADIENT AORTIC VALVE STENOSIS coverClinical reviewsTRANSCATHETER AORTIC VALVE REPLACEMENT OR MEDICAL TREATMENT FOR PARADOXICAL LOW-FLOW, LOW-GRADIENT AORTIC VALVE STENOSISAmerican College of Cardiology Foundation·Cardiology· 2026· 16 pagesThis study investigates the efficacy of transcatheter aortic valve replacement (TAVR) compared to optimal medical therapy (OMT) in patients with paradoxical low-flow, low-gradient aortic stenosis.
ANTICOAGULATION MONOTHERAPY VS ANTIPLATELET MONOTHERAPY AFTER TRANSCATHETER AORTIC VALVE IMPLANT coverClinical reviewsANTICOAGULATION MONOTHERAPY VS ANTIPLATELET MONOTHERAPY AFTER TRANSCATHETER AORTIC VALVE IMPLANTJAMA·Cardiology· 2026· 10 pagesThis study evaluates the safety and efficacy of a factor Xa inhibitor non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy strategy compared to an acetylsalicylic acid (ASA) monotherapy strategy after transcatheter aortic valve implant (TAVI).
AFICAMTEN FOR SYMPTOMATIC NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY coverClinical reviewsAFICAMTEN FOR SYMPTOMATIC NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHYACACIA-HCM Investigators·Cardiology· 2026· 12 pagesThis article discusses the efficacy and safety of aficamten, a cardiac myosin inhibitor, in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM). It presents findings from a phase 3, multinational, double-blind trial.
THE IMPACT OF EARLY CRYOBALLOON ABLATION ON CLINICAL OUTCOMES IN PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION coverClinical reviewsTHE IMPACT OF EARLY CRYOBALLOON ABLATION ON CLINICAL OUTCOMES IN PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATIONTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China; School of Nursing and Health Sciences, Hong Kong·Cardiology· 2025· 8 pagesThis study examines the impact of early cryoballoon ablation on atrial fibrillation recurrence in patients diagnosed with non-paroxysmal atrial fibrillation.
TIMING OF PCI IN PATIENTS UNDERGOING TRANSCATHETER AORTIC-VALVE IMPLANTATION coverClinical reviewsTIMING OF PCI IN PATIENTS UNDERGOING TRANSCATHETER AORTIC-VALVE IMPLANTATIONB.E. Stähli, F. Ruschitzka, D. Westermann, A. Linke, N. Mangner, N.M. Van Mieghem, R. Kesterke, L. Oberholzer, J. Rothe, C. von zur Mühlen, T. Zeus, W.-K. Kim, P. Lauten, N. Werner, C. Burgdorf, H. Alber, P.C. Schulze, M. Joner, J. Michel, A. Candreva,·Cardiology· 13 pagesThis article investigates the timing of percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic-valve implantation (TAVI), focusing on the optimal treatment strategy for patients with concomitant coronary artery disease.
RACIAL DIFFERENCES IN ATRIAL FIBRILLATION MANAGEMENT BETWEEN WHITE PATIENTS AND BLACK PATIENTS IN TRANSTHYRETIN CARDIAC AMYLOID coverClinical reviewsRACIAL DIFFERENCES IN ATRIAL FIBRILLATION MANAGEMENT BETWEEN WHITE PATIENTS AND BLACK PATIENTS IN TRANSTHYRETIN CARDIAC AMYLOIDLindsey R. Mitrani, MD; Robert A. Tumasian, III, BS; Silvia Vilches, MD; Jeffeny De Los Santos, MD, MHA; Esther Gonzalez-Lopez, MD; Angelo Giuseppe Caponetti, MD; Giulia Saturi, MD; Jesus G. Mirelis, MD; Simone Longhi, MD; Christian Gagliardi, MD; Jeff·Cardiology· 7 pagesThis study investigates the differences in atrial fibrillation (AF) management between White and Black patients with transthyretin cardiac amyloidosis (ATTR-CA), highlighting disparities in diagnosis and outcomes.
EPLONTERSEN FOR TRANSTHYRETIN AMYLOID CARDIOMYOPATHY coverClinical reviewsEPLONTERSEN FOR TRANSTHYRETIN AMYLOID CARDIOMYOPATHYCARDIO-TTRansform Investigators·Cardiology· 2024· 12 pagesThis article discusses the effects of eplontersen, an antisense oligonucleotide, on transthyretin amyloidosis with cardiomyopathy (ATTR-CM), a progressive disease caused by the deposition of misfolded transthyretin.
CLOPIDOGREL OR DUAL ANTIPLATELET THERAPY IN HIGH-ISCHEMIC-RISK PATIENTS coverClinical reviewsCLOPIDOGREL OR DUAL ANTIPLATELET THERAPY IN HIGH-ISCHEMIC-RISK PATIENTSSeverance Hospital, Yonsei University·Cardiology· 2026· 12 pagesThis article examines the effects of clopidogrel monotherapy compared to extended dual antiplatelet therapy with clopidogrel and aspirin in patients at high risk for recurrent ischemic events after drug-eluting stent implantation.
COMPLETE REVASCULARIZATION GUIDED BY FUNCTIONAL CORONARY ANGIOGRAPHY IN STEMI coverClinical reviewsCOMPLETE REVASCULARIZATION GUIDED BY FUNCTIONAL CORONARY ANGIOGRAPHY IN STEMIAzienda Ospedaliera Universitaria S. Anna, Cona, Italy·Cardiology· 2026· 10 pagesThis original article discusses the recommended strategy for complete coronary-artery revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, comparing functional coronary angiography with conventional angiography.
CATHETER-DIRECTED THROMBOLYSIS IN INTERMEDIATE-HIGH–RISK PULMONARY EMBOLISM coverClinical reviewsCATHETER-DIRECTED THROMBOLYSIS IN INTERMEDIATE-HIGH–RISK PULMONARY EMBOLISMDepartment of Cardiology, Third Faculty of Medicine, Charles University, Kralovske Vinohrady Hospital, Prague, Czech Republic·Cardiology· 2026· 11 pagesThis original article investigates whether catheter-directed thrombolysis improves clinical outcomes in patients with intermediate-high-risk pulmonary embolism compared to anticoagulation alone.
PreviousPage 17 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount